Camrelizumab
Catalogue number:
HY-P9971-1mg
Supplier:
Size:
1 mg
Product is available in:
Applications:
Cancer-programmed cell death
Target:
PD-1/PD-L1
Alternative Names:
SHR-1210; INCSHR1210
- Data sheet: View or download
- MSDS: View or download
- Protocol: View or download
Product Description:
Camrelizumab (SHR-1210) is a potent humanied high-affinity IgG4-κ monoclonal antibody (mAb) to PD-1. Camrelizumab binds PD-1 at a high affinity of 3 nM and inhibits the binding interaction of PD-1 and PD-L1 with an IC50 of 0.70 nM. Camrelizumab acts as anti-PD-1/PD-L1 agent and can be used for cancer research, including NSCLC, ESCC, Hodgkin lymphoma, and advanced HCC et,al[1][2].